United Health Products, Inc. UEEC
We take great care to ensure that the data presented and summarized in this overview for United Health Products, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding UEEC
View allLatest Institutional Activity in UEEC
Top Purchases
Top Sells
About UEEC
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, assisted living and nursing homes, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Henderson, Nevada.
Insider Transactions at UEEC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2023
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
300,000
-22.15%
|
$0
$0.19 P/Share
|
|
Apr 17
2023
|
Brian David Thom Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
309,375
+18.59%
|
$0
$0.22 P/Share
|
|
Jan 13
2023
|
Brian David Thom Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+19.65%
|
$0
$0.27 P/Share
|
|
Sep 16
2022
|
Brian David Thom Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+11.88%
|
$0
$0.3 P/Share
|
|
Jun 06
2022
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
43,945
-4.57%
|
$0
$0.47 P/Share
|
|
Jun 03
2022
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,055
-5.51%
|
$0
$0.49 P/Share
|
|
Jun 02
2022
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
127,100
-11.1%
|
$0
$0.51 P/Share
|
|
May 04
2022
|
Brian David Thom Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
300,000
+20.76%
|
$0
$0.42 P/Share
|
|
Jan 03
2022
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
220,000
-16.07%
|
$0
$0.54 P/Share
|
|
Nov 22
2021
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
134,000
-8.49%
|
$0
$0.76 P/Share
|
|
Nov 22
2021
|
Brian David Thom Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300,000
+15.97%
|
$0
$0.5 P/Share
|
|
Oct 14
2021
|
Brian David Thom Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
27,102
+2.08%
|
$0
$0.95 P/Share
|
|
Mar 31
2021
|
Kristofer Heaton Principal Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,666
+10.32%
|
$0
$0.5 P/Share
|
|
Mar 31
2021
|
Brian David Thom Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,220,272
+32.61%
|
$0
$0.5 P/Share
|
|
Mar 31
2021
|
Louis Schiliro COO |
BUY
Exercise of conversion of derivative security
|
Direct |
80,173
+2.08%
|
$0
$0.5 P/Share
|
|
Jan 06
2021
|
Douglas K Beplate CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,730,000
+46.19%
|
$0
$0.56 P/Share
|
|
Jan 06
2021
|
Louis Schiliro COO |
BUY
Grant, award, or other acquisition
|
Direct |
2,000,000
+35.09%
|
$2,000,000
$1.04 P/Share
|
|
Jan 06
2021
|
Kristofer Heaton Principal Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+19.8%
|
$100,000
$1.04 P/Share
|
|
Nov 05
2019
|
Douglas K Beplate CEO |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+35.97%
|
$0
$0.97 P/Share
|